Expert Insights
A small but notable number of patients receiving oral anticoagulation will experience a major bleed or require invasive surgery. In these situations, anticoagulation reversal is often essential, but how should reversal be managed in these patients? How should it differ between patients receiving a vitamin K antagonist (VKA), and a non-vitamin K antagonist oral anticoagulant (NOAC)?
Join Professor Donat Spahn, Professor Thorsten Steiner and Dr Oliver Grottke as they discuss best practice in the management of oral anticoagulation reversal.
Oral anticoagulation reversal roundtable discussion
Do the panel think there is still a role for fresh frozen plasma (FFP) in anticoagulation reversal?
Please note, the slides available for download represent a guide to aid discussion; they are not exhaustive and do not necessarily reflect the opinion of the speakers or of Medthority.com.
PCCs effectively reverse warfarin anticoagulation – but how do 3- and 4-Factor PCCs compare?
Please note, the slides available for download represent a guide to aid discussion; they are not exhaustive and do not necessarily reflect the opinion of the speakers or of Medthority.com.
How would the panel manage reversal in patients taking direct factor Xa inhibitors?
Please note, the slides available for download represent a guide to aid discussion; they are not exhaustive and do not necessarily reflect the opinion of the speakers or of Medthority.com.
Join the panel as they discuss the recent approval, and use of, specific factor IIa reversal agents.
Please note, the slides available for download represent a guide to aid discussion; they are not exhaustive and do not necessarily reflect the opinion of the speakers or of Medthority.com.
How would the panel manage an elderly patient receiving warfarin who experiences syncope and contusive head trauma?
Please note, the slides available for download represent a guide to aid discussion; they are not exhaustive and do not necessarily reflect the opinion of the speakers or of Medthority.com.
A patient receiving a NOAC has an ICH – join the panel as they discuss how they would manage this patient.
Please note, the slides available for download represent a guide to aid discussion; they are not exhaustive and do not necessarily reflect the opinion of the speakers or of Medthority.com.
What factors influence a patient’s risk of bleeding on anticoagulation therapy? Join the panel as they discuss the bleeding risks associated with VKAs and NOACs.
Please note, the slides available for download represent a guide to aid discussion; they are not exhaustive and do not necessarily reflect the opinion of the speakers or of Medthority.com.
When to reverse and when to wait. Join the panel as they discuss when anticoagulation reversal should be performed.
Please note, the slides available for download represent a guide to aid discussion; they are not exhaustive and do not necessarily reflect the opinion of the speakers or of Medthority.com.
The panel discuss the currently available anticoagulation reversal options.
Please note, the slides available for download represent a guide to aid discussion; they are not exhaustive and do not necessarily reflect the opinion of the speakers or of Medthority.com.
of interest
are looking at
saved
next event
Job number: KCT16-01-0010
Developed by EPG Health for Medthority in collaboration with CSL Behring, with content provided by CSL Behring.
Not intended for Healthcare Professionals outside Europe.